Summit Therapeutics (SMMT) Revenue (2016 - 2024)
Historic Revenue for Summit Therapeutics (SMMT) over the last 7 years, with Q2 2024 value amounting to -$3.1 million.
- Summit Therapeutics' Revenue changed N/A to -$3.1 million in Q2 2024 from the same period last year, while for Sep 2025 it was $0.0, marking a year-over-year increase of 10000.0%. This contributed to the annual value of $705000.0 for FY2022, which is 6102.82% down from last year.
- Per Summit Therapeutics' latest filing, its Revenue stood at -$3.1 million for Q2 2024.
- Summit Therapeutics' 5-year Revenue high stood at $324311.9 for Q1 2020, and its period low was -$3.1 million during Q1 2024.
- In the last 3 years, Summit Therapeutics' Revenue had a median value of -$1.4 million in 2022 and averaged -$1.4 million.
- Data for Summit Therapeutics' Revenue shows a peak YoY increase of 3357.02% (in 2020) and a maximum YoY decrease of 3357.02% (in 2020) over the last 5 years.
- Summit Therapeutics' Revenue (Quarter) stood at $324311.9 in 2020, then crashed by 32.16% to $220000.0 in 2022, then plummeted by 1510.0% to -$3.1 million in 2024.
- Its Revenue was -$3.1 million in Q2 2024, compared to -$3.1 million in Q1 2024 and $220000.0 in Q3 2022.